Status:

Grey

Decision Date:

July 2024

Comments

GREY: NICE TA922

Daridorexant for treating insomnia in adults with insomnia symptoms lasting for 3 nights or more per week for at least 3 months whose daytime functioning is considerably affected (Decision date - July 2024)

• only if cognitive behavioural therapy for insomnia (CBTi) has been tried but not worked, or CBTi is unsuitable.
• review treatment at 3month and regularly after; not to be put on repeat
• not in patients on psychotropics
• restrict to 12m treatment
• For more information please see: Insomnia - Daridorexant Prescribing Guideline

 

search again